Clinician scientist programme: Cardiovascular phenotyping in patients with cancer: impact of arrhythmias and altered cardiac function on prognosis
| Institution | Charité - Universitätsmedizin Berlin |
|---|---|
| Project leader | Markus Anker |
| Site | Berlin |
| Project type | Exzellenzprogramm |
| Funding | € 245.267,36 |
| Begin | 01.12.2018 |
| End | 29.02.2024 |
Förderkennzeichen
81X3100207
Projektnummer
960